These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 33979630)

  • 1. The potential role of m6A RNA methylation in diabetic retinopathy.
    Kumari N; Karmakar A; Ahamad Khan MM; Ganesan SK
    Exp Eye Res; 2021 Jul; 208():108616. PubMed ID: 33979630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N6-methyladenosine RNA methylation in diabetic kidney disease.
    Huang J; Yang F; Liu Y; Wang Y
    Biomed Pharmacother; 2024 Feb; 171():116185. PubMed ID: 38237350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting epigenetic modifications as a potential therapeutic option for diabetic retinopathy.
    Kumari N; Karmakar A; Ganesan SK
    J Cell Physiol; 2020 Mar; 235(3):1933-1947. PubMed ID: 31531859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-6-Methyladenosine in Vasoactive microRNAs during Hypoxia; A Novel Role for METTL4.
    van den Homberg DAL; van der Kwast RVCT; Quax PHA; Nossent AY
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of m6A methylation in retinal diseases.
    Zhu X; Zhou C; Zhao S; Zheng Z
    Exp Eye Res; 2023 Jun; 231():109489. PubMed ID: 37084873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs: Potential Targets in Diabetic Retinopathy.
    Li X; Yu ZW; Wang Y; Fu YH; Gao XY
    Horm Metab Res; 2020 Mar; 52(3):142-148. PubMed ID: 32215885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of histone modification and DNA methylation in signaling pathways involved in diabetic retinopathy.
    Shafabakhsh R; Aghadavod E; Ghayour-Mobarhan M; Ferns G; Asemi Z
    J Cell Physiol; 2019 Jun; 234(6):7839-7846. PubMed ID: 30515789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-coding RNAs and exosomal non-coding RNAs in diabetic retinopathy: A narrative review.
    Zhong Y; Xia J; Liao L; Momeni MR
    Int J Biol Macromol; 2024 Feb; 259(Pt 1):128182. PubMed ID: 37977468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1 Is Upregulated by Hyperglycemia Via N6-methyladenosine Modification and Promotes Diabetic Retinopathy.
    Sun J; Liu G; Chen R; Zhou J; Chen T; Cheng Y; Lou Q; Wang H
    Discov Med; 2022; 34(172):115-129. PubMed ID: 36333113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology.
    Malovic E; Ealy A; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2021 Apr; 181(1):13-22. PubMed ID: 33616673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of RNA modification N6-methyladenosine in human cancer.
    Zhou Z; Lv J; Yu H; Han J; Yang X; Feng D; Wu Q; Yuan B; Lu Q; Yang H
    Mol Cancer; 2020 Jun; 19(1):104. PubMed ID: 32513173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.
    Xu Z; Lv B; Qin Y; Zhang B
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functions of N6-methyladenosine and its role in cancer.
    He L; Li H; Wu A; Peng Y; Shu G; Yin G
    Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YTHDC1 aggravates high glucose-induced retinal vascular endothelial cell injury via m6A modification of CDK6.
    Zhou Q; Tian M; Cao Y; Tang M; Xiang X; Guo L; Lv H
    Biol Direct; 2024 Jul; 19(1):54. PubMed ID: 38978074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome-wide analysis of N6-methyladenosine uncovers its regulatory role in gene expression in the lepidopteran Bombyx mori.
    Li B; Wang X; Li Z; Lu C; Zhang Q; Chang L; Li W; Cheng T; Xia Q; Zhao P
    Insect Mol Biol; 2019 Oct; 28(5):703-715. PubMed ID: 30957943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy.
    Chang X; Zhu G; Cai Z; Wang Y; Lian R; Tang X; Ma C; Fu S
    Front Endocrinol (Lausanne); 2021; 12():771552. PubMed ID: 34858342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitranscriptomic profiling of N6-methyladenosine-related RNA methylation in rat cerebral cortex following traumatic brain injury.
    Yu J; Zhang Y; Ma H; Zeng R; Liu R; Wang P; Jin X; Zhao Y
    Mol Brain; 2020 Jan; 13(1):11. PubMed ID: 31992337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
    Maity A; Das B
    FEBS J; 2016 May; 283(9):1607-30. PubMed ID: 26645578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.